Pfizer Gets Setback In Lipitor Patent Battle
Lending a boost to Ranbaxy Laboratories' global crusade, a Norwegian court has denied Pfizer Inc.'s claim that the Indian drug maker has infringed two patents related to blockbuster cholesterol drug Lipitor....To view the full article, register now.
Already a subscriber? Click here to view full article